CHECKMATE PHARMACEUTICALS IN
COM · CUSIP 162818108
1
institutional holders
-26 vs Q1 2022
$0reported value*
0 new
0 added
1 reduced
25 sold out
net sold ≈ $54.8m (-17.2m shares)
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable.
Trends to Q2 2022
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2020 | 38 |
| Q4 2020 | 37 |
| Q1 2021 | 38 |
| Q2 2021 | 35 |
| Q3 2021 | 32 |
| Q4 2021 | 26 |
| Q1 2022 | 27 |
| Q2 2022 | 1 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Bought or addedCut or sold out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q4 2020 | 16 | 12 |
| Q1 2021 | 19 | 8 |
| Q2 2021 | 12 | 23 |
| Q3 2021 | 9 | 14 |
| Q4 2021 | 6 | 13 |
| Q1 2022 | 6 | 12 |
| Q2 2022 | 0 | 26 |
Biggest buyers
| None |
Biggest sellers
| venBio Partners LLC | Sold out | -3.7m |
| Sofinnova Investments, Inc. | Sold out | -3.6m |
| NOVO HOLDINGS A/S | Sold out | -2.2m |
| Medicxi Ventures Management (Jersey) Ltd | Reduced | -1.5m |
| Omega Fund Management, LLC | Sold out | -1.3m |
| Decheng Capital Management III (Cayman), LLC | Sold out | -1.3m |
| CLOUGH CAPITAL PARTNERS L P | Sold out | -1.1m |
| FMR LLC | Sold out | -966.2k |
| VANGUARD GROUP INC | Sold out | -556.4k |
| SECTORAL ASSET MANAGEMENT INC | Sold out | -541.8k |
Holders, Q2 2022
| Manager | Shares | Change |
|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd 0.00% of their portfolio | 0 $0 | Reduced -1.5m |